| Firm |
Analyst |
| California Equity Research
|
Bud Leedom |
| Boenning & Scattergood
|
Greg Chodaczek |
| Canaccord Genuity
|
William Plovanic |
| Cowen and Company
|
Doug Schenkel |
| Jefferies & Company, Inc.
|
Raj Denhoy |
| Lazard Capital Markets
|
Patrick Clingan |
| Maxim Group LLC
|
Vivian Cervantes |
| Noble Financial
|
Jan Wald |
| RBC Capital Markets
|
Glenn Novarro |
| Rodman & Renshaw
|
Analyst to be named |
| Roth Capital Partners
|
Matt Dolan |
Alphatec Spine is covered by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Alphatec Spine's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Alphatec Spine or its management. Alphatec Spine does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
|
